Chapel Hill, North Carolina 27599


The purpose of the study is to assess the time, dose dependence, and fraction-size dependence of radiation (RT)-induced changes in regional lung and heart perfusion/function/structure following thoracic RT delivered using newer IMRT/conformal/radiosurgery techniques. The PI hopes to develop models to better relate and predict RT-induced changes in regional lung and heart perfusion/function/structure with changes in global cardiopulmonary function. Patients will undergo pre- and serial post-RT lung and heart assessments to better understand RT-induced regional heart/lung changes.


Inclusion Criteria: 1. Age ≥ 18 years 2. Patients who are to receive 3D-planned RT for tumor within and around the thorax. 3. Patients receiving incidental RT to portions of the heart are eligible. 4. Estimated minimum expected life expectancy of one year 5. Able to undergo the required study-related tests for regional lung injury and regional heart injury 6. Patients of child bearing potential age must have a negative pregnancy test and must agree to use appropriate birth control measures while in the study. 7. Patients must be able to give informed consent. Informed consent will be obtained prior to enrollment. Exclusion Criteria: 1. Patients who are anticipated to have thoracic surgery post-RT are ineligible. 2. Patients with large mediastinal/hilar tumors compressing the airways/vessels, and negatively impacting on cardiovascular function 3. Pregnant or nursing women.



Primary Contact:

Principal Investigator
Lawrence Marks, MD
University of North Carolina at Chapel Hill, Department of Radiation Oncology

Lawrence Marks, MD
Phone: (919) 966-7700

Backup Contact:

Rebecca Green, MSW
Phone: (984) 974-8440

Location Contact:

Chapel Hill, North Carolina 27599
United States

Lawrence Marks, MD
Phone: 919-966-7700

Site Status: Recruiting

Data Source:

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.